GSK
  • About
  • Press Releases
    Latest
    English 259
  • Assets
    Images
    Files
    Other
  • Resources
    Website
    facebook twitter youtube linkedin instagram

About GSK

We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together.

We prioritise innovation in vaccines and specialty medicines to prevent and treat disease.

GSK
1 year ago ⋅ English ⋅ 3 min read
Newsroom

GSK announces positive results from DREAMM-8 phase III trial for Blenrep versus standard of care combination in relapsed/refractory multiple myeloma

For media and investors only- Trial unblinded early at an interim analysis based on Independent Data Monitoring Committee recommendation- Blenrep (belantamab mafodotin) plus PomDex show... Read More

GSK
1 year ago ⋅ English ⋅ 4 min read
Newsroom

ViiV Healthcare announces interim data at CROI indicating superior efficacy of long-acting injectable HIV treatment Cabenuva (cabotegravir + rilpivirine) compared to daily oral therapy in individuals living with HIV who have adherence challenges

For media and investors onlyViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced data from a... Read More

View All Press Releases

Wire Association

© Copyright 2025
Wire Association. All rights reserved.
Helpful Links
  • Login
  • Home
  • About
  • Contact
Press Releases
  • Pricing
  • News Center
  • Editorial Guidelines
  • Editorial Team
Other
  • Terms & Conditions
  • Privacy Policy
  • Sitemap